Name of Drug Generic Name: Lithium Carbonate Brand Name: Eskalith

Classification Antimanic drug

Indication Treatment of manic episodes of bipolar disorder; maintenance therapy to prevent or diminish frequency and intensity of subsequent manic episodes.

Contraindication Adverse Reaction Lithium should generally not be given to patients with significant renal or cardiovascular disease, dehydtation, sodium depletion, patients on diuretics (lithium decreases sodium reabsorption, and hyponatremia increase lithium retention) Diarrhea, vomiting, drowsiness, muscular weakness and lack of coordination may be early signs of lithium toxicity, and can occur at lithium levels below 2 mEq/l. At higher levels, giddiness, ataxia, blurred vision, tinnitus, polyuria

Packaging preparation Tablet (300mg)

Nsg. Responsibility Observe for signs of lithium toxicity, monitor urine output